← SynDRA
GLPG-0974
SynDRA canonical compound SYN0038116 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | FFAR2 |
|---|
| Mechanism of action | free fatty acid receptor antagonist |
|---|
| Indication | ulcerative colitis |
|---|
| Disease area | gastroenterology |
|---|
All known targets
Mechanisms of action (all sources)
- FFAR2 ANTAGONIST
- Free fatty acid receptor 2 antagonist
- free fatty acid receptor antagonist
Cross-references
Synonyms
- GLPG 0974
- GLPG0974
- compound 99 [PMID 25380412]
- X7REK61AIS
- RefChem:143520
- MPMKMQHJHDHPBE-RUZDIDTESA-N
- A1LYD
- UNII-X7REK61AIS
- C25H25ClN2O4S
- GTPL8417
- orb1707266
- SCHEMBL11298599
- SCHEMBL29352637
- GLXC-10358
- EX-A2832
- RFC07661
- BDBM50032334
- MFCD28502087
- AKOS027470232
- EBC-521573
- SB16999
- AC-36690
- DA-73763
- HY-12940
- MS-29019
- CS-0012804
- G14486
- T15388
- 4-[[(2R)-1-(1-benzothiophene-3-carbonyl)-2-methylazetidine-2-carbonyl]-[(3-chlorophenyl)methyl]amino]butanoic acid
Look up GLPG-0974 in the interactive SynDRA portal →